The plasma lipidomic signature of nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

The plasma lipidomic signature of nonalcoholic steatohepatitis.

The plasma lipidomic signature of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q37272567

about

Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases Hypoxia signaling pathways: modulators of oxygen-related organelles Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases Collagen Induced Arthritis in DBA/1J Mice Associates with Oxylipin Changes in Plasma Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease 12- and 15-lipoxygenases in adipose tissue inflammation Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Inflammation in nonalcoholic steatohepatitis.Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.The metabolomic window into hepatobiliary disease.ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload.Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.ADV36 adipogenic adenovirus in human liver disease.Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat De Novo Lipogenesis Products and Endogenous Lipokines.The influence of dietary fat on liver fat accumulation.Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.NLRP3 inflammasome activation is required for fibrosis development in NAFLD.Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis.Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression

P2860

Q21559453-4878559A-7B13-4DF0-9451-D0B0994A9051 Q26741550-37922C9C-F974-41AB-A3FD-A424699D0B32 Q26799950-866C006A-A467-412B-B416-14874F2CCCB6 Q27021694-D447E0BC-9AD7-471D-942A-26DD1BB49726 Q27315389-22F868E2-FE67-4CDC-BB9C-EF3F5CBF31FE Q27887317-39CEA410-D605-4ABB-BEC4-718366F36F90 Q28072381-D32D6E21-80D6-410C-8460-73074C23223C Q28274315-F66548E1-2984-4751-938F-5AABF09CF62B Q28485117-3BD1A5EA-5CAB-4133-B57A-12F4D49B4C33 Q30412771-46B8073E-6121-436F-BB8A-C2188BFBEE58 Q30453231-0E6297A3-21AA-4238-A44E-A1C57C5B378C Q33665070-A2A1E09C-0AE5-4357-A1B2-E9729DB79784 Q33684205-8927AD17-4166-462F-8799-800177B2783C Q33765372-417E30E7-2ACC-42B3-AC06-B9294BE6A177 Q33893457-364323A6-C19A-4EF5-9329-6EFD6F2AD6E2 Q33906433-D9BEA832-E8A0-4F60-8509-4E7370FF8D12 Q33998998-D23D65A5-E6C4-43A3-95C9-E5959293FCAB Q34103693-57AA9178-4DDC-4307-A65D-E1C1F21B1C9B Q34152594-19DD51EA-B094-42B1-ABCB-81379CEE58FF Q34328111-4E62299E-A79A-4D3F-894A-5D6BBFD1B0D3 Q34332185-B5AE5F94-1234-4C84-AFBC-7701857E056D Q34366966-45AFB85E-A14E-4E2F-8B8B-65E915C1C8A7 Q34405050-D37CA12A-C436-40D8-A878-E97B372CF890 Q34483949-A6F962AB-6993-4D60-8ACA-CB10EBDE7E7F Q34530470-8151236D-7CAE-4E5B-8264-38D8CC5852B0 Q34578071-23303B68-CF13-4185-BBEC-D0B43E7E2D45 Q34658087-FCE30CC3-DFF5-4D6A-9EAB-DA486ADBC9D0 Q34704820-E5C331B2-B71E-4845-B007-A442DF3C354A Q34750585-D94AA581-C7AB-41BE-83B4-590A71DAD151 Q34757421-321E5F84-E4AA-4637-BDA1-FF642ECC0DBD Q35018573-45B27DFD-0A9F-44A7-B4B3-FCBAA1F82C6A Q35020458-5BCCAD92-02AF-4109-BE05-0296B3B57295 Q35066362-4984B619-0500-4658-9F38-5D3C3F437107 Q35120968-9493CD92-B883-4ED1-AC01-218BA18ACA17 Q35146713-F233BF94-BD2E-4025-A913-B23512DE11D9 Q35172447-66AE02E8-8AE9-414F-B169-F836B5E41D83 Q35220587-987757F8-AC6E-488A-B9F7-CC30A32FE688 Q35550990-12907028-ECED-4BD6-A999-059BF63B261D Q35849928-BC7D314F-06AC-47CE-99F6-433290F6ADA3 Q35874842-2281240C-0BB1-4059-B7F3-758A67962543

P2860

The plasma lipidomic signature of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q37272567

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@en

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@nl

type

label

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@en

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@nl

prefLabel

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@en

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@nl

P1433

Q37272567-72662DE1-CE38-4751-B7D4-3F1DD05650F6

P1476

Q37272567-057B42F7-A644-450D-A717-F9992018C290

P2093

Q37272567-1ADF47E1-D85B-46E0-BD68-736E03498595

Q37272567-491529D5-A644-489D-8BC9-0864611668B5

Q37272567-6037AA94-0E5A-4BE4-AF6F-7B205C07D66E

Q37272567-941E1315-0710-4439-B207-CA4DAFB6408A

Q37272567-A5E55C4D-59AE-4A30-B48A-A6128FCCF4C3

Q37272567-A689D090-FADF-4677-8E6F-969AD5003133

Q37272567-BAD2065B-3AC8-47E9-9E38-C04EA970CD08

Q37272567-BEE2A530-36CB-4255-B5BC-E81FF942A279

Q37272567-CAE51228-F7E5-4F4E-A307-1569200013FE

Q37272567-D1B10BB8-AAB1-4080-9F65-3F4D409DF47E

P2860

Q37272567-23CCFB4F-F029-4D2F-8644-542ACD3E0256

Q37272567-23DC07A2-DF15-4827-A21A-F18C6DA11AED

Q37272567-28BFB90B-E706-42C1-9E1E-2AF03AEFF963

Q37272567-2A474C01-2D7D-43A3-BCD0-4B4D1276AB88

Q37272567-2CA7E775-30C2-4EE3-A6D2-F354B0DEA362

Q37272567-4D170FED-4B72-4829-ACD6-70318BE5CC1C

Q37272567-5A4458BE-7AAC-4B45-AD19-87BBC230C726

Q37272567-629A24B2-F215-40A1-B4B9-180C158777C6

Q37272567-6ECDDD9F-5C06-4AF0-93B2-5E7B37B84E6F

Q37272567-766DB17C-36B0-4101-9775-57DCBDA8BE5D

P304

Q37272567-79B65C06-D1F4-4244-92D7-0E363042BCC3

P31

Q37272567-403AF7E7-3EE0-4DDF-B336-AFF26A6E5CC5

P356

Q37272567-688E963F-A5FB-47E5-BC10-58EB86A9E2C2

P407

Q37272567-4AA266B8-21BA-4F5D-83E0-367208A1A829

P433

Q37272567-7BE26A9E-5885-4297-8934-E96F2D6C54DC

P478

Q37272567-387775BD-248A-4ABC-AEC3-98D80C6A7FDE

P577

Q37272567-EBA3ADC2-FB59-4325-AC3C-B5D257C82660

P5875

Q37272567-992A4837-E167-4ED4-8A5A-DE63BF081637

P698

Q37272567-C00B071F-B007-4228-912E-76F1B212A52E

P921

Q37272567-3C6B9526-D389-4949-B3D6-6B9957B35C4E

P932

Q37272567-8F305638-BF66-4DD7-8A42-7F5C5FA627E7

P356

P1433

P1476

The plasma lipidomic signature of nonalcoholic steatohepatitis.

@en

P2093

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Carol Sargeant

http://www.w3.org/2001/XMLSchema#string

Faridoddin Mirshahi

http://www.w3.org/2001/XMLSchema#string

Hae-Ki Min

http://www.w3.org/2001/XMLSchema#string

Huiping Zhou

http://www.w3.org/2001/XMLSchema#string

Melissa J Contos

http://www.w3.org/2001/XMLSchema#string

Michael Fuchs

http://www.w3.org/2001/XMLSchema#string

Michelle M Wiest

http://www.w3.org/2001/XMLSchema#string

Onpan Cheung

http://www.w3.org/2001/XMLSchema#string

Puneet Puri

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin signalling and the regulation of glucose and lipid metabolism

Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism

A simple method for the isolation and purification of total lipides from animal tissues

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

P304

1827-1838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23229

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40030926

http://www.w3.org/2001/XMLSchema#string

P698

19937697

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5031239

http://www.w3.org/2001/XMLSchema#string